UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.849

Sortiert nach

Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

Alimentary pharmacology & therapeutics, 2016-01, Vol.43 (S1), p.11-26

Bajaj, J. S.

2016

Link zum Volltext

Verfügbarkeit prüfen

Review article: the modern management of hepatic encephalopathy

Alimentary pharmacology & therapeutics, 2010-03, Vol.31 (5), p.537-547

BAJAJ, J. S.

2010

Link zum Volltext

Verfügbarkeit prüfen

Review article: the design of clinical trials in hepatic encephalopathy – an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement

Alimentary pharmacology & therapeutics, 2011-04, Vol.33 (7), p.739-747

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1113-1125

2014

Link zum Volltext

Verfügbarkeit prüfen

Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis

Alimentary pharmacology & therapeutics, 2012-11, Vol.36 (9), p.866-874

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictors of the recurrence of hepatic encephalopathy in lactulose‐treated patients

Alimentary pharmacology & therapeutics, 2010-05, Vol.31 (9), p.1012-1017

2010

Link zum Volltext

Verfügbarkeit prüfen

Statin use and infections in Veterans with cirrhosis

Alimentary pharmacology & therapeutics, 2013-09, Vol.38 (6), p.611-618

2013

Link zum Volltext

Verfügbarkeit prüfen

PROMIS computerised adaptive tests are dynamic instruments to measure health‐related quality of life in patients with cirrhosis

Alimentary pharmacology & therapeutics, 2011-11, Vol.34 (9), p.1123-1132

2011

Link zum Volltext

Verfügbarkeit prüfen

Non‐selective beta‐blockers are not associated with serious infections in veterans with cirrhosis

Alimentary pharmacology & therapeutics, 2013-08, Vol.38 (4), p.407-414

2013

Link zum Volltext

Verfügbarkeit prüfen

Modified-orientation log to assess hepatic encephalopathy

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (8), p.913-920

2012

Link zum Volltext

Verfügbarkeit prüfen

Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (2), p.319-331

2017

Link zum Volltext

Verfügbarkeit prüfen

Editorial: patient‐reported outcomes in chronic HCV—a PROMISing approach to an ongoing problem

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1319-1320

2018

Link zum Volltext

Verfügbarkeit prüfen

Editorial: should the inappropriate use of proton pump inhibitors be a quality assurance issue in cirrhotic patients?

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (3), p.476-477

2017

Link zum Volltext

Verfügbarkeit prüfen

Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes

The American journal of gastroenterology, 2017-07, Vol.112 (7), p.1103-1110

2017

Link zum Volltext

Verfügbarkeit prüfen

Commentary: probing probiotics in cirrhosis – a template for future studies? Author's reply

Alimentary pharmacology & therapeutics, 2014-06, Vol.39 (11), p.1335-1336

Bajaj, J. S.

2014

Link zum Volltext

Verfügbarkeit prüfen

Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

Alimentary pharmacology & therapeutics, 2015-01, Vol.41 (1), p.39-45

2015

Link zum Volltext

Verfügbarkeit prüfen

Beta‐blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.78-85

2018

Link zum Volltext

Verfügbarkeit prüfen

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

Alimentary pharmacology & therapeutics, 2016-09, Vol.44 (6), p.638-643

2016

Link zum Volltext

Verfügbarkeit prüfen

Postoperative management of noniatrogenic traumatic bile duct injuries : role of endoscopic retrograde cholangiopancreaticography

Surgical endoscopy, 2006-06, Vol.20 (6), p.974-977

2006

Link zum Volltext

Verfügbarkeit prüfen

Commentary: TIPSS for Budd‐Chiari syndrome

Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (10), p.1237-1238

2014

Link zum Volltext

Verfügbarkeit prüfen

High‐dose vitamin E supplementation does not diminish ribavirin‐associated haemolysis in hepatitis C treatment with combination standard α‐interferon and ribavirin

Alimentary pharmacology & therapeutics, 2004-11, Vol.20 (10), p.1189-1193

2004

Link zum Volltext

Verfügbarkeit prüfen

Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections

Hepatology international, 2024, Vol.18 (3), p.817-832

2024

Link zum Volltext

Verfügbarkeit prüfen

Commentary: non‐haemodynamic effects of beta‐blockers in cirrhosis – more than meets the eye? Authors’ reply

Alimentary pharmacology & therapeutics, 2013-09, Vol.38 (6), p.653-653

2013

Link zum Volltext

Verfügbarkeit prüfen

Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary

Metabolic brain disease, 2016-10, Vol.31 (5), p.1081-1093

2016

Link zum Volltext

Verfügbarkeit prüfen

Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion

Alimentary pharmacology & therapeutics, 2011-07, Vol.34 (1), p.103-105

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.849

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.625)
Mit Volltextzugriff
(1.632)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

Review article: the modern management of hepatic encephalopathy

Review article: the design of clinical trials in hepatic encephalopathy – an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis

Predictors of the recurrence of hepatic encephalopathy in lactulose‐treated patients

Statin use and infections in Veterans with cirrhosis

PROMIS computerised adaptive tests are dynamic instruments to measure health‐related quality of life in patients with cirrhosis

Non‐selective beta‐blockers are not associated with serious infections in veterans with cirrhosis

Modified-orientation log to assess hepatic encephalopathy

Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

Editorial: patient‐reported outcomes in chronic HCV—a PROMISing approach to an ongoing problem

Editorial: should the inappropriate use of proton pump inhibitors be a quality assurance issue in cirrhotic patients?

Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes

Commentary: probing probiotics in cirrhosis – a template for future studies? Author's reply

Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

Beta‐blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

Postoperative management of noniatrogenic traumatic bile duct injuries : role of endoscopic retrograde cholangiopancreaticography

Commentary: TIPSS for Budd‐Chiari syndrome

High‐dose vitamin E supplementation does not diminish ribavirin‐associated haemolysis in hepatitis C treatment with combination standard α‐interferon and ribavirin

Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections

Commentary: non‐haemodynamic effects of beta‐blockers in cirrhosis – more than meets the eye? Authors’ reply

Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary

Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion

Suchergebnisse filtern